Correlation Between Cardio Diagnostics and XTL Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and XTL Biopharmaceuticals Ltd, you can compare the effects of market volatilities on Cardio Diagnostics and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and XTL Biopharmaceutica.
Diversification Opportunities for Cardio Diagnostics and XTL Biopharmaceutica
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cardio and XTL is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and XTL Biopharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and XTL Biopharmaceutica go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and XTL Biopharmaceutica
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 5.28 times more return on investment than XTL Biopharmaceutica. However, Cardio Diagnostics is 5.28 times more volatile than XTL Biopharmaceuticals Ltd. It trades about 0.4 of its potential returns per unit of risk. XTL Biopharmaceuticals Ltd is currently generating about 0.05 per unit of risk. If you would invest 41.00 in Cardio Diagnostics Holdings on September 12, 2024 and sell it today you would earn a total of 111.00 from holding Cardio Diagnostics Holdings or generate 270.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. XTL Biopharmaceuticals Ltd
Performance |
| Timeline |
| Cardio Diagnostics |
| XTL Biopharmaceuticals |
Cardio Diagnostics and XTL Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and XTL Biopharmaceutica
The main advantage of trading using opposite Cardio Diagnostics and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| XTL Biopharmaceutica vs. Benitec Biopharma Ltd | XTL Biopharmaceutica vs. Xenetic Biosciences | XTL Biopharmaceutica vs. ProPhase Labs | XTL Biopharmaceutica vs. BOS Better Online |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |